Literature DB >> 2924218

Validity of the 20 m shuttle run test with 1 min stages to predict VO2max in adults.

L Léger1, C Gadoury.   

Abstract

The purpose of this study was to assess the validity of the 1 min stage version of the 20 m shuttle run multistage test to predict VO2max in adults (53 males and 24 females, 19 to 47 years old). The maximal shuttle run speed (S-MAS) was thus compared to the VO2max attained during a multistage treadmill test (TE-VO2max), the retroextrapolated VO2max at time zero of the O2 recovery curve of the shuttle run (SR-VO2max) and the VO2max predicted from a previously developed regression equation with children (Mercier et al., 1983) and putting 18 year olds in the regression equation for all adults which yielded (SP-VO2max = -27.4 + 6.0 S-MAS). The latter regression equation was very similar to the ones obtained with the two other criteria and was thus retained to ensure a smooth transition between children and adults in predicting VO2max. Correlations and standard errors of the estimate between S-MAS and TE-VO2max (r = 0.90 and Syx = 4.4) or SR-VO2max (r = 0.87 and Syx = 4.7) were quite good. TE-, SR- and SP-VO2max were also similar (mean +/- SD = 49.4 +/- 10.1, 48.8 +/- 9.3 and 47.1 +/- 8.3 mL.kg-1.min-1, respectively, p greater than 0.05). It was concluded that the 20 m shuttle run is a valid test to predict VO2max in adults.

Entities:  

Mesh:

Year:  1989        PMID: 2924218

Source DB:  PubMed          Journal:  Can J Sport Sci        ISSN: 0833-1235


  34 in total

1.  A prediction equation to estimate the maximum oxygen uptake of school-age girls from kolkata, India.

Authors:  Pinaki Chatterjee; Alok K Banerjee; Paulomi Das
Journal:  Malays J Med Sci       Date:  2011-01

2.  Enhancing the efficacy of the 20 m multistage shuttle run test.

Authors:  A D Flouris; G S Metsios; Y Koutedakis
Journal:  Br J Sports Med       Date:  2005-03       Impact factor: 13.800

3.  Effectiveness of a home-based balance-training program in reducing sports-related injuries among healthy adolescents: a cluster randomized controlled trial.

Authors:  Carolyn A Emery; J David Cassidy; Terry P Klassen; Rhonda J Rosychuk; Brian H Rowe
Journal:  CMAJ       Date:  2005-03-15       Impact factor: 8.262

Review 4.  Time-motion analysis and physiological data of elite under-19-year-old basketball players during competition.

Authors:  Nidhal Ben Abdelkrim; Saloua El Fazaa; Jalila El Ati
Journal:  Br J Sports Med       Date:  2006-11-30       Impact factor: 13.800

5.  The energy cost of shuttle running.

Authors:  Antonio Buglione; Pietro Enrico di Prampero
Journal:  Eur J Appl Physiol       Date:  2013-01-09       Impact factor: 3.078

6.  Ergogenic effect of varied doses of coffee-caffeine on maximal aerobic power of young African subjects.

Authors:  Sikiru Lamina; D I Musa
Journal:  Afr Health Sci       Date:  2009-12       Impact factor: 0.927

7.  Comparing several equations that predict peak VO2 using the 20-m multistage-shuttle run-test in 8-10-year-old children.

Authors:  Xavier Melo; Helena Santa-Clara; José Pedro Almeida; Elvis Alvarez Carnero; Luís Bettencourt Sardinha; Paula Marta Bruno; Bo Fernhall
Journal:  Eur J Appl Physiol       Date:  2010-11-10       Impact factor: 3.078

Review 8.  Developing legally defensible physiological employment standards for prominent physically demanding public safety occupations: a Canadian perspective.

Authors:  V Jamnik; R Gumienak; N Gledhill
Journal:  Eur J Appl Physiol       Date:  2013-03-14       Impact factor: 3.078

9.  A modified exercise protocol may promote continuance of exercise after the intervention in lung cancer patients--a pragmatic uncontrolled trial.

Authors:  Andreas H Andersen; Anders Vinther; Lise-Lotte Poulsen; Anders Mellemgaard
Journal:  Support Care Cancer       Date:  2013-03-20       Impact factor: 3.603

10.  Does an individual's fitness level affect baseline concussion symptoms?

Authors:  Martin Mrazik; Dhiren Naidu; Constance Lebrun; Alex Game; Joan Matthews-White
Journal:  J Athl Train       Date:  2013-04-03       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.